SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

Shiba Inu is currently a major focus of community debate, with investors split between those anticipating a major breakout driven by ecosystem developments and others dismissing the asset as a speculative project. Many participants are actively monitoring potential burn mechanisms and network updates while debating the long-term viability of the token compared to other meme coins.

Dogecoin is an open-source digital currency based on the "Doge" meme that functions as a peer-to-peer medium for fast payments and digital tipping. Unlike projects backed by corporate entities, its value is driven by a global community, and the project is managed by a decentralized group of volunteers and the non-profit Dogecoin Foundation rather than a formal company.  Originally created in 2013 by software engineers Billy Markus and Jackson Palmer as a market parody, the project held no public sale or venture capital rounds. The network operates as a fork of LuckyCoin, which itself was a fork of Litecoin, using a proof of work consensus mechanism. It employs the Scrypt algorithm to ensure the mining process remains fast and efficient, with new blocks processed every 60 seconds. A unique technical feature is its use of merged mining, allowing miners to secure Dogecoin simultaneously with other Scrypt-based networks like Litecoin.  To keep transaction fees low and the network running indefinitely, Dogecoin features an uncapped supply where new coins are added forever. In a major regulatory milestone in March 2026, a joint SEC and CFTC framework officially classified Dogecoin as a digital commodity, placing it in the same asset category as gold or oil.

Dogecoin

Dogecoin is capturing attention as retail investors remain divided, with many debating whether to hold long-term based on its ties to high-profile figures or abandon the asset amid concerns of stagnation and market volatility. While some community members are betting on a future rally and comparing the coin to broader crypto market movements, others express deep frustration, characterizing it as a speculative trap and calling for rotation into newer utility-based tokens.

Avalanche is a high throughput smart contract blockchain&nbsp;platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

Avalanche is currently trending due to intense community debate surrounding its sharp decline toward multi-year lows and concerns over potential capitulation. Investors are actively discussing whether the current price levels represent a high-upside accumulation opportunity or a value trap, with many drawing comparisons to other volatile sectors and speculating on the impact of future regulatory clarity.

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

Astrazeneca plc

AstraZeneca PLC

AstraZeneca is trending as investors weigh strong oncology pipeline performance and the potential for a U.S. tariff exemption deal following reports of high-level negotiations regarding drug pricing. Community sentiment is mixed, with some focusing on long-term growth and dividend stability, while others monitor the volatility surrounding clinical trial results and regulatory news.

Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of therapeutics for metabolic dysfunction-associated steatohepatitis. The company was founded by Rebecca A. Taub, Frederick Bernard Craves, and Edward Chiang on March 10, 2000 and is headquartered in West Conshohocken, PA.

Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals is seeing heightened investor attention following a significant price target upgrade from Citizens, which cites the company's strong Rezdiffra launch and the strategic expansion of its MASH pipeline as primary drivers. While some participants are adjusting expectations regarding a near-term buyout, the broader community remains focused on the company's potential as a dominant market leader in MASH treatment.

ProShares Trust II - ProShares Ultra Silver 2x Shares

ProShares Ultra Silver

ProShares Ultra Silver is attracting intense community attention as traders debate whether the recent volatility represents a buying opportunity or a deeper correction linked to U.S. interest rate sensitivity and industrial demand. Investors are actively discussing the risks of leveraged decay versus the potential for a rebound, while closely monitoring the metal's performance against dollar strength and macroeconomic catalysts.

Listed Funds Trust - Roundhill Magnificent Seven ETF

Roundhill Magnificent Seven ETF

The Roundhill Magnificent Seven ETF (MAGS) is facing significant selling pressure as investors rotate away from mega-cap tech and weigh the long-term impact of heavy AI capital expenditures on corporate balance sheets. Market participants remain sharply divided, with many monitoring whether this dip represents a healthy consolidation or a structural shift away from the leadership that has dominated index returns.

X-Energy, Inc. operates as an energy company The firm focuses on modular nuclear reactors and fuel technology for clean energy generation. The company was founded by Kam Ghaffarian and Eben Mulder on 2009 and is headquartered in Rockville, MD.

X-Energy Inc. - Ordinary Shares- Class A

X-energy Inc

X-energy is currently trending as a prominent play in the nuclear-AI sector following its inclusion as a Tier 1 partner in the DOE-backed Project Prometheus, an initiative alongside NVIDIA and AWS to accelerate AI-driven nuclear reactor deployment. Community sentiment is largely focused on the company's long-term potential as a critical infrastructure provider for power-hungry data centers, though investors remain cautious about the significant execution risks and the timeline associated with transitioning from development to commercial-scale energy production.

Philip Morris International, Inc. is a holding company, which engages in the business of delivering a smoke-free future and evolving a portfolio for the long term to include products outside of the tobacco and nicotine sector. It operates through the following geographical segments: Europe Region (Europe), South and Southeast Asia, Commonwealth of Independent States, Middle East, and Africa Region (SSEA, CIS, and MEA), East Asia, Australia, and PMI Global Travel Retail (EA, AU, and PMI GTR), and Americas Region (Americas). The Europe segment includes all the European Union countries, Switzerland, the United Kingdom, Ukraine, Moldova, and Southeast Europe. The SSEA, CIS, and MEA segment focuses on South and Southeast Asia, the African continent, the Middle East, Turkey, Israel, Central Asia, Caucasus, and Russia. The EA, AU, and PMI GTR segment is involved in the consolidation of international duty-free business with East Asia and Australia. The Americas segment consists of the United States, Canada, and Latin America. The company was founded by Philip Morris in 1847 and is headquartered in Stamford, CT.

Philip Morris International Inc

Philip Morris International is experiencing high volatility as investors weigh strong earnings and raised full-year guidance against a quarterly revenue miss and concerns over slowing shipment volumes. The community remains focused on the long-term smoke-free transformation, with intense debate centered on the competitive battle between Zyn and Velo and the stock's potential for a rebound.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is drawing heavy attention ahead of the upcoming ASCO conference, where the company will present pivotal clinical data for its lead bispecific antibody, ivonescimab. While some analysts have expressed skepticism regarding competitive pressure and regulatory hurdles, the community remains highly focused on the potential for this data to challenge established cancer standards, with significant insider interest and high short interest fueling intense debate about the stock's future trajectory.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Humanoid War Robot Gets Advanced AMD-Powered AI Brain

Humanoid War Robot Gets Advanced AMD-Powered AI Brain

 At the start of February, we began tracking startup Foundation Robotics after publicly available news reports and X posts suggested it could become one of the first US companies to deploy humanoid robots on the modern...

AMD Stock Slips Despite Wave Of Price Target Hikes – Retail Traders Say Chip Rally Is 'Starting To Look Exhausted' 

Equity

Baird doubled its price target on AMD stock to $1,250, while UBS, Bank of America, Roth Capital and Jefferies also lifted their targets.


Is INTC Stock Still Worth Buying After Its Strong 2026 Recovery Rally

Intel's 2026 rally is being driven by stronger AI demand, improving foundry execution and robust quarterly results as its turnaround gains traction.

Intel AI and Foundry Trends Could Shape INTC Growth in Coming Years

Intel is expanding AI across PCs, enterprise systems and foundry services as manufacturing progress and infrastructure demand reshape its growth outlook.

Intel Stock Outlook as AI and Foundry Growth Reshape INTC Strategy

INTC is reshaping around AI, foundry services and enterprise infrastructure as improving execution and customer adoption reinforce its turnaround strategy.

NXPI to Report Q2 Earnings: What's in Store for the Stock?

NXP Semiconductors heads into second-quarter earnings with automotive, Industrial & IoT growth against supply chain pressures and macroeconomic headwinds.

Can AMD Partnership Strengthen Cerebras' AI Infrastructure Leadership?

CBRS teams up with AMD on a disaggregated AI inference platform targeting ultra-low latency, high throughput and up to 5X better efficiency.


AMD CEO Lisa Su on AI demand and hyperscaler spending: 'We're seeing the returns'

AMD CEO Lisa Su on AI demand and hyperscaler spending: 'We're seeing the returns...

Advanced Micro Devices (AMD) Boasts Earnings & Price Momentum: Should You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.

A Small AI Company Just Took the Stage at One of the Biggest Events in Computing, and It Points to Where Drug Discovery Is Headed

A Small AI Company Just Took the Stage at One of the Biggest Events in Computing, and It Points to Where Drug Discovery Is Headed A Small AI Company Just Took the Stage at One of the Biggest Events in Computing, and It Points to Where Drug Discovery Is Headed PR Newswire AUSTIN, Texas, July 24...

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Bullish Sentiment

AMD stock price today, news, financials, forum, discussion, community insights, and trading ideas, join 10 million+ investors and traders tracking markets in real-time on Stocktwits.

AMD Stock Price Today, Analysis, News and Trading Ideas

Buying $MRVL

Buying $FLEX

Buying both

Not buying either

$MRVL and $FLEX are being added to the S&amp;P 500 - are you buying either of them on the news?

Stocktwits

Marvell Technology Inc

Flex Ltd

 are being added to the S&P 500 - are you buying either of them on the news?

Stocktwits Polls

Advanced Micro Devices Inc

Wall Street is rapidly raising price targets, with some analysts now forecasting figures as high as $1,250 based on expanding data center demand.

Traders are intensely debating whether the stock will dump or skyrocket ahead of earnings, fearing that gains are already priced in.

Short-term call buyers are complaining about market maker volatility as options expiry creates intense price swings and whipsaw action.

Technical traders are watching key support levels closely, with a major standoff occurring between bulls defending the $500–$530 zone and bears seeking a breakdown.

Niche discussions are shifting toward memory-intensive AI workloads, highlighting how HBM capacity is becoming a competitive performance advantage.

Feed

News

Sentiment

Earnings

Fundamentals

Info

AMDAdvanced Micro Devices Inc

Fundamentals

Latest AMD News